Patents by Inventor Bernard Mouillac

Bernard Mouillac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide antagonists of the vasopressin-2 receptor
    Patent number: 9631001
    Abstract: The invention relates to a new group of snake venom basic protease inhibitors having vasopressin-2 receptor antagonist activity that can be used in therapy, diagnosis, medical imaging, drug screening and research.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: April 25, 2017
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITY OF REGENSBURG, UNIVERSITY DE LIEGE
    Inventors: Nicolas Gilles, Denis Servent, Loïc Quinton, Helen Reinfrank, Ralph Witzgall, Bernard Mouillac, Christiane Mendre
  • PEPTIDE ANTAGONISTS OF THE VASOPRESSIN-2 RECEPTOR
    Publication number: 20150252086
    Abstract: The invention relates to a new group of snake venom basic protease inhibitors having vasopressin-2 receptor antagonist activity that can be used in therapy, diagnosis, medical imaging, drug screening and research.
    Type: Application
    Filed: September 17, 2013
    Publication date: September 10, 2015
    Inventors: Nicolas Gilles, Denis Servent, Loïc Quinton, Helen Reinfrank, Ralph Witzgall, Bernard Mouillac, Christiane Mendre
  • Method for producing a recombinant protein of interest and protein thus produced
    Publication number: 20070149766
    Abstract: A fragment of an alpha-integrin for producing at least one recombinant protein of interest in a cell, with the exception of a mammalian cell.
    Type: Application
    Filed: June 18, 2004
    Publication date: June 28, 2007
    Applicant: INSERM
    Inventors: Bernard Mouillac, Jean-Louis Baneres, Tuhinadri Sen